| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 47,321 | 50,037 | 49,686 | 65,779 | | Cost of Revenue | 27,438 | 29,032 | 29,528 | 38,911 | | | Gross Profit | 19,883 | 21,005 | 20,158 | 26,868 | | | Operating Expenses | | Research Development | 439 | 387 | 563 | 569 | | Selling General and Administrative | 11,756 | 12,182 | 12,622 | 16,571 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,688 | 8,436 | 6,973 | 9,728 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,972 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 9,814 | 8,436 | 6,973 | 9,728 | | Interest Expense | 252 | 282 | 312 | 189 | | Income Before Tax | 10,408 | 8,154 | 6,661 | 9,539 | | Income Tax Expense | 3,640 | 2,896 | 2,214 | 3,342 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,768 | 5,258 | 4,447 | 6,197 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,768 | 5,258 | 4,447 | 6,197 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,768 | $5,258 | $4,447 | $6,197 |
|
0.59% Nasdaq 
Income Statement
